Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid.
Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid. J Immunol. 2004 Sep 15; 173(6):4171-8.
View in:
PubMed
subject areas
Adjuvants, Immunologic
Animals
Anti-Inflammatory Agents, Non-Steroidal
Autoantibodies
CD3 Complex
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Cells, Cultured
Disease Progression
Female
Glomerular Mesangium
Histocompatibility Antigens Class II
Histone Deacetylase Inhibitors
Hydroxamic Acids
Immunosuppressive Agents
Inflammation Mediators
Injections, Intraperitoneal
Lupus Erythematosus, Systemic
Lymphopenia
Mice
Mice, Inbred MRL lpr
Organ Size
Proteinuria
Spleen
authors with profiles
Gary S. Gilkeson